Pages that link to "Q37413862"
Jump to navigation
Jump to search
The following pages link to Sphingosine-1-phosphate receptor signalling in the heart (Q37413862):
Displaying 50 items.
- Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial (Q24564715) (← links)
- The role of sphingosine-1-phosphate in endothelial barrier function (Q26862336) (← links)
- The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat (Q28484640) (← links)
- The Sphingosine-1-phospate receptor 1 mediates S1P action during cardiac development (Q28512659) (← links)
- Lipid receptor S1P₁ activation scheme concluded from microsecond all-atom molecular dynamics simulations (Q28534072) (← links)
- FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia (Q28743446) (← links)
- Identification of cardiac hemo-vascular precursors and their requirement of sphingosine-1-phosphate receptor 1 for heart development (Q29878960) (← links)
- Hemovascular Progenitors in the Kidney Require Sphingosine-1-Phosphate Receptor 1 for Vascular Development. (Q30278407) (← links)
- Sphingosine-1-phosphate as an amphipathic metabolite: its properties in aqueous and membrane environments (Q33498660) (← links)
- Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel-group, phase I study in healthy subjects (Q33593619) (← links)
- The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion (Q33613072) (← links)
- Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes (Q33634084) (← links)
- Characterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart (Q33720344) (← links)
- Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis? (Q33753317) (← links)
- The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population (Q33756452) (← links)
- Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. (Q33815638) (← links)
- Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion (Q34113032) (← links)
- Synergy between sphingosine 1-phosphate and lipopolysaccharide signaling promotes an inflammatory, angiogenic and osteogenic response in human aortic valve interstitial cells (Q34282317) (← links)
- Early double-negative thymocyte export in Trypanosoma cruzi infection is restricted by sphingosine receptors and associated with human chagas disease (Q34351157) (← links)
- Improving heart function by modulating myocardiocyte autophagy: a possible novel mechanism for cardiovascular protection of high-density lipoprotein (Q34439003) (← links)
- Granule cargo release from bone marrow-derived cells sustains cardiac hypertrophy (Q34519433) (← links)
- Cardiovascular effects of fingolimod: A review article. (Q34558943) (← links)
- S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart (Q34979795) (← links)
- Insulin protects apoptotic cardiomyocytes from hypoxia/reoxygenation injury through the sphingosine kinase/sphingosine 1-phosphate axis (Q35069407) (← links)
- Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system (Q35130512) (← links)
- Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy (Q35535621) (← links)
- An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease (Q35545433) (← links)
- Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion (Q35563422) (← links)
- Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries (Q36119717) (← links)
- Pharmacological Elevation of Circulating Bioactive Phosphosphingolipids Enhances Myocardial Recovery After Acute Infarction (Q36212627) (← links)
- Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation (Q36416533) (← links)
- Essential role of class II phosphatidylinositol-3-kinase-C2α in sphingosine 1-phosphate receptor-1-mediated signaling and migration in endothelial cells (Q36561963) (← links)
- Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects (Q36620247) (← links)
- Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling (Q37087108) (← links)
- Lyase to live by: sphingosine phosphate lyase as a therapeutic target (Q37414484) (← links)
- Sphingosine-1-phosphate signaling in physiology and diseases. (Q38016831) (← links)
- Lysophospholipid receptor activation of RhoA and lipid signaling pathways (Q38044174) (← links)
- Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure (Q38045551) (← links)
- Fingolimod for the treatment of relapsing multiple sclerosis (Q38112209) (← links)
- Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease (Q38262594) (← links)
- Therapeutic potential of HDL in cardioprotection and tissue repair (Q38293492) (← links)
- Unravelling the interplay of sphingolipids and TGF-β signaling in the human corneal stroma (Q38625631) (← links)
- Lysophospholipids and their G protein-coupled receptors in atherosclerosis (Q38643186) (← links)
- S1P receptor 1-Mediated Anti-Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2. (Q38703649) (← links)
- Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis. (Q38937414) (← links)
- Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs (Q39838646) (← links)
- Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6. (Q41237635) (← links)
- Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System (Q41531207) (← links)
- Phos-tag SDS-PAGE resolves agonist- and isoform-specific activation patterns for PKD2 and PKD3 in cardiomyocytes and cardiac fibroblasts (Q41649719) (← links)
- Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. (Q41829826) (← links)